B16 tumors were transferred into wt C57BL/6 mice, and the mice later immunized with either tumor antigen-pulsed BM-DCs or EGFR-blocking nanobodies, BM-DCs in combination with EGFR-blocking nanobodies, or alone. This evidence concerns the gene EGFR and neoplasm.